Your browser doesn't support javascript.
loading
Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-Gi Complex Structures.
Hua, Tian; Li, Xiaoting; Wu, Lijie; Iliopoulos-Tsoutsouvas, Christos; Wang, Yuxia; Wu, Meng; Shen, Ling; Brust, Christina A; Nikas, Spyros P; Song, Feng; Song, Xiyong; Yuan, Shuguang; Sun, Qianqian; Wu, Yiran; Jiang, Shan; Grim, Travis W; Benchama, Othman; Stahl, Edward L; Zvonok, Nikolai; Zhao, Suwen; Bohn, Laura M; Makriyannis, Alexandros; Liu, Zhi-Jie.
Afiliação
  • Hua T; iHuman Institute, ShanghaiTech University, Shanghai 201210, China. Electronic address: huatian@shanghaitech.edu.cn.
  • Li X; iHuman Institute, ShanghaiTech University, Shanghai 201210, China.
  • Wu L; iHuman Institute, ShanghaiTech University, Shanghai 201210, China.
  • Iliopoulos-Tsoutsouvas C; Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, MA 02115, USA.
  • Wang Y; iHuman Institute, ShanghaiTech University, Shanghai 201210, China.
  • Wu M; iHuman Institute, ShanghaiTech University, Shanghai 201210, China; School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
  • Shen L; iHuman Institute, ShanghaiTech University, Shanghai 201210, China; School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
  • Brust CA; Departments of Molecular Medicine and Neuroscience, Scripps Research, Jupiter, FL 33458, USA.
  • Nikas SP; Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, MA 02115, USA.
  • Song F; School of Life Science, Dezhou University, Dezhou 253023, Shandong Province, China.
  • Song X; Institute of Molecular and Clinical Medicine, Kunming Medical University, Kunming 650500, Yunnan Province, China.
  • Yuan S; The Research Center for Computer-aided Drug Discovery, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
  • Sun Q; iHuman Institute, ShanghaiTech University, Shanghai 201210, China.
  • Wu Y; iHuman Institute, ShanghaiTech University, Shanghai 201210, China.
  • Jiang S; Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, MA 02115, USA.
  • Grim TW; Departments of Molecular Medicine and Neuroscience, Scripps Research, Jupiter, FL 33458, USA.
  • Benchama O; Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, MA 02115, USA.
  • Stahl EL; Departments of Molecular Medicine and Neuroscience, Scripps Research, Jupiter, FL 33458, USA.
  • Zvonok N; Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, MA 02115, USA.
  • Zhao S; iHuman Institute, ShanghaiTech University, Shanghai 201210, China; School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
  • Bohn LM; Departments of Molecular Medicine and Neuroscience, Scripps Research, Jupiter, FL 33458, USA.
  • Makriyannis A; Center for Drug Discovery and Department of Pharmaceutical Sciences, Northeastern University, Boston, MA 02115, USA; Center for Drug Discovery and Departments of Chemistry and Chemical Biology, Northeastern University, Boston, MA 02115, USA.
  • Liu ZJ; iHuman Institute, ShanghaiTech University, Shanghai 201210, China; School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China; Institute of Molecular and Clinical Medicine, Kunming Medical University, Kunming 650500, Yunnan Province, China. Electronic address: liuzhj@shan
Cell ; 180(4): 655-665.e18, 2020 02 20.
Article em En | MEDLINE | ID: mdl-32004463
Human endocannabinoid systems modulate multiple physiological processes mainly through the activation of cannabinoid receptors CB1 and CB2. Their high sequence similarity, low agonist selectivity, and lack of activation and G protein-coupling knowledge have hindered the development of therapeutic applications. Importantly, missing structural information has significantly held back the development of promising CB2-selective agonist drugs for treating inflammatory and neuropathic pain without the psychoactivity of CB1. Here, we report the cryoelectron microscopy structures of synthetic cannabinoid-bound CB2 and CB1 in complex with Gi, as well as agonist-bound CB2 crystal structure. Of important scientific and therapeutic benefit, our results reveal a diverse activation and signaling mechanism, the structural basis of CB2-selective agonists design, and the unexpected interaction of cholesterol with CB1, suggestive of its endogenous allosteric modulating role.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Subunidades alfa Gi-Go de Proteínas de Ligação ao GTP / Receptor CB1 de Canabinoide / Receptor CB2 de Canabinoide / Agonistas de Receptores de Canabinoides Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Subunidades alfa Gi-Go de Proteínas de Ligação ao GTP / Receptor CB1 de Canabinoide / Receptor CB2 de Canabinoide / Agonistas de Receptores de Canabinoides Idioma: En Ano de publicação: 2020 Tipo de documento: Article